National Health Investors (NYSE:NHI) had its price objective dropped by Wells Fargo & Co from $82.00 to $51.00 in a research report issued on Thursday, BenzingaRatingsTable reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Co‘s price target suggests a potential downside of 1.75% from the company’s current price.

A number of other analysts have also recently weighed in on the stock. Mizuho reissued a “buy” rating and set a $95.00 price objective on shares of National Health Investors in a report on Friday, December 20th. Berenberg Bank assumed coverage on shares of National Health Investors in a research note on Wednesday, February 5th. They issued a “buy” rating and a $94.00 price objective on the stock. Finally, BMO Capital Markets upgraded shares of National Health Investors from an “underperform” rating to a “market perform” rating and boosted their target price for the stock from $74.00 to $82.00 in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $82.40.

National Health Investors stock traded up $3.14 during midday trading on Thursday, hitting $51.91. 9,540 shares of the stock were exchanged, compared to its average volume of 601,443. National Health Investors has a fifty-two week low of $31.37 and a fifty-two week high of $91.12. The stock has a market capitalization of $1.91 billion, a price-to-earnings ratio of 14.05 and a beta of 0.35. The stock’s 50-day simple moving average is $74.37 and its 200 day simple moving average is $80.39. The company has a current ratio of 16.40, a quick ratio of 16.40 and a debt-to-equity ratio of 0.96.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.95 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.41 by ($0.46). National Health Investors had a return on equity of 11.07% and a net margin of 50.44%. The firm had revenue of $82.20 million for the quarter, compared to analyst estimates of $79.92 million. During the same quarter in the previous year, the business posted $1.35 earnings per share. National Health Investors’s revenue for the quarter was up 11.1% on a year-over-year basis. Equities analysts anticipate that National Health Investors will post 5.69 EPS for the current fiscal year.

In related news, Director Robert T. Webb purchased 2,151 shares of the firm’s stock in a transaction on Monday, March 16th. The stock was purchased at an average price of $46.28 per share, for a total transaction of $99,548.28. Following the acquisition, the director now directly owns 63,339 shares in the company, valued at $2,931,328.92. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director W Andrew Adams purchased 27,000 shares of the firm’s stock in a transaction on Monday, March 23rd. The stock was bought at an average price of $36.16 per share, with a total value of $976,320.00. Following the acquisition, the director now owns 759,784 shares in the company, valued at $27,473,789.44. The disclosure for this purchase can be found here. 5.11% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of National Health Investors in the 4th quarter valued at $43,207,000. Bank of New York Mellon Corp increased its position in National Health Investors by 32.3% during the fourth quarter. Bank of New York Mellon Corp now owns 793,760 shares of the real estate investment trust’s stock worth $64,675,000 after purchasing an additional 193,903 shares during the last quarter. Kennedy Capital Management Inc. increased its position in National Health Investors by 97.9% during the fourth quarter. Kennedy Capital Management Inc. now owns 243,381 shares of the real estate investment trust’s stock worth $19,831,000 after purchasing an additional 120,383 shares during the last quarter. Marshall Wace LLP increased its position in National Health Investors by 19,516.1% during the fourth quarter. Marshall Wace LLP now owns 83,957 shares of the real estate investment trust’s stock worth $6,841,000 after purchasing an additional 83,529 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in National Health Investors by 9.5% during the fourth quarter. Geode Capital Management LLC now owns 610,121 shares of the real estate investment trust’s stock worth $49,712,000 after purchasing an additional 53,107 shares during the last quarter. Hedge funds and other institutional investors own 70.65% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More: Trading Ex-Dividend

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.